Bayer’s proposed purchase of Monsanto would bring the German pharmaceutical giant deep into the lucrative but socially controversial business of genetically modified crops, paring the share of health care in its business.
from WSJ.com: US Business http://ift.tt/1TO54Aq
via IFTTT
No comments:
Post a Comment